Litcius/Paper detail

Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists

Francesco Prattichizzo, Paola de Candia, Antonio Ceriello

2021Metabolism74 citationsDOI

Topics & Concepts

MedicineDiabetes mellitusDiseaseKidney diseaseNephropathyDiabetic nephropathyType 2 diabetesClinical trialBioinformaticsGlucagon-like peptide 1 receptorIntensive care medicinePharmacologyInternal medicineEndocrinologyReceptorBiologyAgonistDiabetes Treatment and ManagementPancreatic function and diabetesMetabolism, Diabetes, and Cancer
Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists | Litcius